Today, Congresswoman Nikki Budzinski (IL-13) hosted a roundtable with independent pharmacists, pharmacy students and faculty ...

The "middlemen of medicine" have become obstacles to progress, often perpetuating inefficiencies and exacerbating healthcare's existing problems.

Leqembi, along with rare disease and depression treatments, helped offset a year-over-year decline in revenue for the company ...

No matter what happens in this election, the government should work for the people. The government may not be perfect, but it ...

It remains to be seen how well President Joe Biden’s Inflation Reduction Act will actually work in lowering prescription drug ...

Doha Mekki, the No. 2 official in the U.S. Justice Department’s Antitrust Division, said her agency is investigating whether it should take action in the health care space generally, and specifically ...

Pharmacy Benefit Managers are the middlemen who manage virtually all prescriptions written in the U.S. Serving as brokers among drugmakers, pharmacies, and health insurers, these health care entities ...

A drug pricing expert reveals the shocking cost disparity of a life-saving spinal muscular atrophy drug in India, priced at ...

The company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health ...

Elizabeth Warren seeks scrutiny of deals that would allow drug middlemen McKesson, Cardinal Health, and Cencora to also ...

Congresswoman Nikki Budzinski (IL-13) will host a roundtable discussion with independent pharmacists on Saturday, November 2, ...

PBMs represent insurers in drug transactions, and they decide which medicines will be covered. And, because just three PBMs control access to about 80% of insured patients, they have enormous ...